litlas
Log inCreate account

Shusen Zheng

Active 2002–2025

355
Papers
30,155
Citations
96
h-index
328
i10-index

Citations

Citations per year for Shusen Zheng1905: 1 citations1945: 1 citations1992: 1 citations1998: 1 citations2002: 4 citations2003: 24 citations2004: 25 citations2005: 38 citations2006: 42 citations2007: 63 citations2008: 131 citations2009: 127 citations2010: 138 citations2011: 153 citations2012: 221 citations2013: 211 citations2014: 225 citations2015: 225 citations2016: 215 citations2017: 233 citations2018: 228 citations2019: 840 citations2020: 1,127 citations2021: 1,353 citations2022: 1,280 citations2023: 1,120 citations2024: 1,858 citations2025: 1,001 citations2026: 33 citations1906–1944: no citations, so these years are not shown1946–1991: no citations, so these years are not shown1993–1997: no citations, so these years are not shown1999–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 4,975 citing papers, 35.2% of this breakdownUnited States: 2,404 citing papers, 17% of this breakdownUnited Kingdom: 549 citing papers, 3.9% of this breakdownItaly: 532 citing papers, 3.8% of this breakdownGermany: 421 citing papers, 3% of this breakdownCanada: 321 citing papers, 2.3% of this breakdownJapan: 297 citing papers, 2.1% of this breakdownFrance: 291 citing papers, 2% of this breakdownIndia: 291 citing papers, 2% of this breakdownAustralia: 270 citing papers, 1.9% of this breakdownSpain: 265 citing papers, 1.9% of this breakdownSouth Korea: 253 citing papers, 1.8% of this breakdown
0%35.2%Other 23.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology45.7%
  • Medicine41.9%
  • Immunology and Microbiology5%
  • Engineering1.5%
  • Materials Science1.3%
  • Nursing0.7%
  • Other3.9%

Topics

  • Cancer-related molecular mechanisms research5.1%
  • RNA modifications and cancer4.3%
  • Gut microbiota and health2.8%
  • Liver Disease Diagnosis and Treatment2.8%
  • MicroRNA in disease regulation2.7%
  • Hepatocellular Carcinoma Treatment and Prognosis2.6%
  • Other79.7%

Coauthors

All papers

Open in search
  1. Extracellular matrix and its therapeutic potential for cancer treatment

    Authors: Jiacheng Huang, Lele Zhang, Dalong Wan, Lin Zhou, Shusen Zheng, Shengzhang Lin, Yiting Qiao - Signal Transduction and Targeted Therapy 2021 cited by 918

  2. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis

    Authors: Yingying Yu, Li Jiang, Hao Wang, Zhe Shen, Qi Cheng, Pan Zhang, Jiaming Wang, Qian Wu, Xuexian Fang, Lingyan Duan, Shufen Wang, Kai Wang, Peng An, Tuo Shao, Raymond T. Chung, Shusen Zheng, Junxia Min, Fudi Wang - Blood 2020 cited by 596

  3. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma

    Authors: Zhigang Ren, Ang Li, Jianwen Jiang, Lin Zhou, Zujiang Yu, Haifeng Lu, Haiyang Xie, Xiaolong Chen, Li Shao, Ruiqing Zhang, Shaoyan Xu, Hua Zhang, Guangying Cui, Xinhua Chen, Ranran Sun, Hao Wen, Jan Lerut, Quancheng Kan, Lanjuan Li, Shusen Zheng - Gut 2018 cited by 794

  4. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

    Authors: Yunhao Chen, Chuanhui Peng, Junru Chen, Diyu Chen, Beng Yang, Bin He, Wendi Hu, Yanpeng Zhang, Hua Liu, Longfei Dai, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng - Molecular Cancer 2019 cited by 671

  5. Quality of Information in Gallstone Disease Videos on TikTok: Cross-sectional Study

    Authors: Fei Sun, Shusen Zheng, Jian Wu - Journal of Medical Internet Research 2023 cited by 193

  6. Blocking Triggering Receptor Expressed on Myeloid Cells‐1‐Positive Tumor‐Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti‐Programmed Cell Death Ligand 1 Resistance in Liver Cancer

    Authors: Qinchuan Wu, Wuhua Zhou, Shengyong Yin, Yuan Zhou, Tianchi Chen, Junjie Qian, Rong Su, Liangjie Hong, Haohao Lu, Feng Zhang, Haiyang Xie, Lin Zhou, Shusen Zheng - Hepatology 2019 cited by 267

  7. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

    Authors: Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu - Molecular Cancer 2019 cited by 379

  8. Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model

    Authors: Shuai Wang, Qinchuan Wu, Tianchi Chen, Rong Su, Caixu Pan, Junjie Qian, Hechen Huang, Shengyong Yin, Haiyang Xie, Lin Zhou, Shusen Zheng - Journal of Hepatology 2022 cited by 171

  9. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion

    Authors: Deguo Zhang, Da Man, Jiahua Lu, Yifan Jiang, Bo Ding, Rong Su, Rongliang Tong, Junru Chen, Beng Yang, Shusen Zheng, Diyu Chen, Jian Wu - Advanced Science 2023 cited by 132

  10. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway

    Authors: Junru Chen, Chaofeng Ding, Yunhao Chen, Wendi Hu, Chengkuan Yu, Chuanhui Peng, Xiaode Feng, Qiyang Cheng, Wenxuan Wu, Yuejie Lu, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng - Cancer Letters 2020 cited by 223

  11. Quality and Reliability of Liver Cancer–Related Short Chinese Videos on TikTok and Bilibili: Cross-Sectional Content Analysis Study

    Authors: Shusen Zheng, Xinyu Tong, Dalong Wan, Chen Hu, Qing Hu, Qinghong Ke - Journal of Medical Internet Research 2023 cited by 188

  12. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    Authors: Hui‐Chuan Sun, Jian Zhou, Zheng Wang, Xiufeng Liu, Qing Xie, Weidong Jia, Ming Zhao, Xinyu Bi, Li Gong, Xueli Bai, Yuan Ji, Li Xu, Xiao‐Dong Zhu, Dousheng Bai, Yajin Chen, Yongjun Chen, Chaoliu Dai, Rong Guo, Wenzhi Guo, Chunyi Hao, Tao Huang, Zhiyong Huang, Deyu Li, Gang Li, Tao Li, Xiangcheng Li, Guangming Li, Liang Xiao, Jingfeng Liu, Fubao Liu, Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan - HepatoBiliary Surgery and Nutrition 2022 cited by 198

  13. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1

    Authors: Yunhao Chen, Yanchun Zhao, Junru Chen, Chuanhui Peng, Yanpeng Zhang, Rongliang Tong, Qiyang Cheng, Beng Yang, Xiaode Feng, Yuejie Lu, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng - Molecular Cancer 2020 cited by 305

  14. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma

    Authors: Hechen Huang, Zhigang Ren, Xingxing Gao, Xiaoyi Hu, Yuan Zhou, Jianwen Jiang, Haifeng Lu, Shengyong Yin, Junfang Ji, Lin Zhou, Shusen Zheng - Genome Medicine 2020 cited by 198

  15. Application of metagenomics in the human gut microbiome

    Authors: Weilin Wang, Shaoyan Xu, Zhigang Ren, Liang Tao, Jianwen Jiang, Shusen Zheng - World Journal of Gastroenterology 2015 cited by 407

  16. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

    Authors: Beng Yang, Xiaode Feng, Hua Liu, Rongliang Tong, Jingbang Wu, Changbiao Li, Hanxi Yu, Yunhao Chen, Qiyang Cheng, Junru Chen, Xianlei Cai, Wenxuan Wu, Yuejie Lu, Jiating Hu, Kejiong Liang, Zhen Lv, Jian Wu, Shusen Zheng, Jian Wu, Shusen Zheng - Oncogene 2020 cited by 197

  17. Activation of YAP1 by N6-Methyladenosine–Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma

    Authors: Yunhao Chen, Zhenan Ling, Xianlei Cai, Yongfang Xu, Zhen Lv, Da Man, Jiangzhen Ge, Chengkuan Yu, Deguo Zhang, Yanpeng Zhang, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng - Cancer Research 2021 cited by 131

  18. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation

    Authors: Sunbin Ling, Qiaonan Shan, Qifan Zhan, Qianwei Ye, Peng Liu, Shengjun Xu, Xin He, Jian Ma, Jiajia Xiang, Guangjiang Jiang, Xue Wen, Zijie Feng, Yuan Wu, Tingting Feng, Li Xu, Kangchen Chen, Xuanyu Zhang, Rongli Wei, Chenzhi Zhang, Beini Cen, Haiyang Xie, Penghong Song, Jimin Liu, Shusen Zheng, Xiao Xu - Gut 2019 cited by 229

  19. Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China

    Authors: Zhigang Ren, Jianwen Jiang, Haiyang Xie, Ang Li, Haifeng Lu, Shaoyan Xu, Lin Zhou, Hua Zhang, Guangying Cui, Xinhua Chen, Yuanxing Liu, Liming Wu, Nan Qin, Ranran Sun, Wei Wang, Lanjuan Li, Weilin Wang, Shusen Zheng - Oncotarget 2017 cited by 233

  20. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference

    Authors: Neil Mehta, Prashant Bhangui, Francis Y. Yao, Vincenzo Mazzaferro, Christian Toso, Nobuhisa Akamatsu, François Durand, Jan N.M. IJzermans, Wojciech G. Polak, Shusen Zheng, John P. Roberts, Gonzalo Sapisochín, Taizo Hibi, Nancy Man Kwan, R. Mark Ghobrial, Avi Soin - Transplantation 2020 cited by 214

  21. Cancer‐associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma

    Authors: Aibin Zhang, Yigang Qian, Ye Zhou, Haiyong Chen, Haiyang Xie, Lin Zhou, Yan Shen, Shusen Zheng - Cancer Medicine 2017 cited by 213

  22. Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

    Authors: Xingxing Gao, Hechen Huang, Caixu Pan, Zhibin Mei, Shengyong Yin, Lin Zhou, Shusen Zheng - Cancers 2022 cited by 71

  23. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis

    Authors: Longxian Lv, Daiqiong Fang, Ding Shi, Deying Chen, Yan Ren, Yixin Zhu, Yanfei Chen, Li Shao, Feifei Guo, Wenrui Wu, Ang Li, Haiyan Shi, Xiawei Jiang, Huiyong Jiang, Yonghong Xiao, Shusen Zheng, Lanjuan Li - Environmental Microbiology 2016 cited by 261

  24. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

    Authors: Juxian Sun, Rong Guo, Xinyu Bi, Mengchao Wu, Zhao–You Tang, Wan Yee Lau, Shusen Zheng, Xuehao Wang, Jinming Yu, Xiaoping Chen, Jia Fan, Jiahong Dong, Yongjun Chen, Yunfu Cui, Chaoliu Dai, Chihua Fang, Shuang Feng, Zhili Ji, Weidong Jia, Ningyang Jia, Li Gong, Jing Li, Qiu Li, Jiangtao Li, Tingbo Liang, Lianxin Liu, Shichun Lu, Yi Lv, Yilei Mao, Yan Meng, Zhiqiang Meng, Feng Shen, Jie Shi, Hui‐Chuan Sun, Kaishan Tao, Gao‐Jun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xu–Ting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhao‐Chong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng - Liver Cancer 2022 cited by 110